Stephane Bancel

On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna’s recently unveiled post-COVID roadmap. The Moderna Trade Ark Invest’s ARK Genomic Revolution...

Moderna, Inc. (NASDAQ: MRNA) CEO Stéphane Bancel appeared on CNBC's "Squawk Box" Thursday to discuss the company's promising new cancer vaccine developed in partnership with Merck & Company, Inc. (NYSE: MRK). What Happened: When combined with Keytruda, Moderna...

Short Hills Capital's Steve Weiss once predicted Moderna Inc (NASDAQ: MRNA) shares would make an Amazon-like move. Since then, the stock has been cut in half twice, and now he's dumping a large portion of his position alongside the CEO of the company. What Happened: In 2021,...

The annual Time 100 Most Influential People list for 2022 contains names such as U.S. President Joe Biden, Ukrainian President Volodymyr Zelenskyy and Chinese President Xi Jinping. The list also has several CEOs and names connected to public companies. Here are several of the names on the...

Moderna Inc (NASDAQ: MRNA) shares are down more than 40% since the start of the year and continue to trend lower Monday. Vaccine stocks are facing selling pressure as the COVID-19 omicron variant fades, but Moderna investors have been expressing concerns...

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older. SPIKEVAX, the company's mRNA Covid-19 vaccine, has now...

Moderna Inc (NASDAQ: MRNA) is trading higher Monday following the company's pipeline update at the JP Morgan Healthcare Conference. Moderna announced that it now has 40 programs in development, including 23 in ongoing clinical studies, encompassing mRNA infectious disease...

Moderna Inc (NASDAQ: MRNA) is trading higher Monday morning after the company announced preliminary booster data.  The company's authorized booster (50 microgram dose of mRNA-1273) increases omicron neutralizing antibody levels approximately 37-fold. Moderna also said...

Moderna Inc (NASDAQ: MRNA) is trading lower Friday after the company announced interim Phase 1 data for its mRNA flu vaccine. Moderna said mRNA-1010 successfully boosted hemagglutination inhibition (HAI) assay geometric mean titers against all strains 29 days after vaccination at all...

Moderna Inc (NASDAQ: MRNA) is trading higher Monday amid increasing concerns surrounding the omicron COVID-19 variant.  Omicron has more than 30 mutations on the spike protein that binds to human cells, according to a World Health Organization report. The mutations suggest ...

Global markets fell sharply Friday amid increasing fears about a new COVID-19 variant, omicron. "I don't believe many people would have predicted such a big jump in evolution in one variant," Moderna Inc (NASDAQ: MRNA) CEO Stéphane Bancel said...

Moderna Inc (NASDAQ: MRNA) is trading higher on continued strength Monday after the U.S. Food and Drug Administration last week authorized booster doses of the company's COVID-19 vaccine in the US for adults 18 and older. The booster can be used in all individuals 18 years and...

Moderna Inc (NASDAQ: MRNA) is trading higher Friday after the company announced the U.S. Food and Drug Administration authorized its booster dose of COVID-19 vaccine in the U.S. for adults 18 and older. The booster can be used in all individuals 18 years and older who have...

Moderna Inc (NASDAQ: MRNA) is trading higher Wednesday after the company filed for authorization of its COVID-19 vaccine, a 50 microgram two-dose series of SPIKEVAX, with Health Canada to include children ages six to 11. Health Canada approved the New Drug Submission for...

Moderna Inc (NASDAQ: MRNA) is trading higher Friday after the company announced the FDA Advisory Committee unanimously voted in support of Emergency Use for a booster dose of the company's COVID-19 vaccine in the US. Moderna's booster is half the dose of the first two shots (...